These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33161376)

  • 1. Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool.
    Sebastian A; Kayani A; Prieto-Pena D; Tomelleri A; Whitlock M; Mo J; van der Geest N; Dasgupta B
    RMD Open; 2020 Nov; 6(3):. PubMed ID: 33161376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis.
    Prieto Peña D; Martínez-Rodríguez I; Atienza-Mateo B; Calderón-Goercke M; Banzo I; González-Vela MC; Castañeda S; Llorca J; González-Gay MÁ; Blanco R
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):69-75. PubMed ID: 33253103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis.
    Conticini E; Sota J; Falsetti P; Baldi C; Bardelli M; Bellisai F; Tosi GM; Frediani B; Cantarini L
    Mediators Inflamm; 2020; 2020():3203241. PubMed ID: 33061825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.
    Nielsen BD; Hansen IT; Keller KK; Therkildsen P; Gormsen LC; Hauge EM
    Rheumatology (Oxford); 2020 Aug; 59(8):2062-2073. PubMed ID: 31808526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis.
    Hop H; Mulder DJ; Sandovici M; Glaudemans AWJM; van Roon AM; Slart RHJA; Brouwer E
    Rheumatology (Oxford); 2020 Dec; 59(12):3676-3684. PubMed ID: 32240306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
    Imfeld S; Aschwanden M; Rottenburger C; Schegk E; Berger CT; Staub D; Daikeler T
    Rheumatology (Oxford); 2020 Apr; 59(4):772-778. PubMed ID: 31436837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
    Quinn KA; Dashora H; Novakovich E; Ahlman MA; Grayson PC
    Rheumatology (Oxford); 2021 Sep; 60(9):4384-4389. PubMed ID: 33369678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy.
    Higashida-Konishi M; Akiyama M; Shimada T; Hama S; Oshige T; Izumi K; Oshima H; Okano Y
    Rheumatol Int; 2023 Mar; 43(3):545-549. PubMed ID: 36152056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
    Unizony S; McCulley TJ; Spiera R; Pei J; Sidiropoulos PN; Best JH; Birchwood C; Pavlov A; Stone JH
    Arthritis Res Ther; 2021 Jan; 23(1):8. PubMed ID: 33407817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
    Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG
    J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
    Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
    Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
    Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of
    Hay B; Mariano-Goulart D; Bourdon A; Benkiran M; Vauchot F; De Verbizier D; Ben Bouallègue F
    Ann Nucl Med; 2019 Jul; 33(7):512-520. PubMed ID: 30976984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.
    Schönau V; Roth J; Tascilar K; Corte G; Manger B; Rech J; Schmidt D; Cavallaro A; Uder M; Crescentini F; Boiardi L; Casali M; Spaggiari L; Galli E; Kuwert T; Versari A; Salvarani C; Schett G; Muratore F
    Rheumatology (Oxford); 2021 Aug; 60(8):3851-3861. PubMed ID: 33831144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and follow-up of 60 patients with recent diagnosis of giant cell arteritis, NEWTON study].
    Lomba Goncalves N; Tran VT; Chauffier J; Bourdin V; Nassarmadji K; Vanjak A; Bigot W; Burlacu R; Champion K; Lopes A; Depont A; Borrero BA; Mangin O; Adle-Biassette H; Bonnin P; Boutigny A; Bonnin S; Neumann L; Mouly S; Sène D; Comarmond C
    Rev Med Interne; 2024 Jun; 45(6):335-342. PubMed ID: 38216390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis.
    Ince B; Işik EG; Özkan ZG; Yalçinkaya Y; Esen BA; Gül A; Inanç M
    Turk J Med Sci; 2024; 54(1):69-75. PubMed ID: 38812633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.